Eclipse Corporate Finance

What Eclipse Corporate Finance does

Eclipse Corporate Finance is a boutique mergers and acquisitions advisory firm exclusively focused on the UK healthcare sector. Founded in 2019 and headquartered in Chipping Norton, the firm is a private limited company registered in England & Wales (registered number 11791669) and regulated by the Institute of Chartered Accountants of Scotland for investment business activities. Its core offer comprises company sales, private equity transactions (including management buy-outs and capital raises) and strategic advice, delivered by a team of chartered accountants with hands-on deal execution experience. The firm specialises in advising healthcare business owners whose businesses generate £1m-£5m of annual EBITDA, while its practitioners reference deal experience of up to £100m in transaction value. Eclipse does not develop or deploy proprietary technology products; its deliverables are advisory services, market insights and confidential sale processes.

The firm covers ten healthcare sub-verticals, including clinical services, digital health and software, dental practices and labs, specialist residential care, children's services and SEN schools, care homes, day nurseries, homecare/domiciliary care, veterinary services, and pharma services. Revenue is generated through advisory fees linked to transaction valuations and is event-driven. Deal origination relies on direct outreach, professional referrals, sector reputation and inbound enquiries generated by a published thought-leadership programme of monthly Healthcare M&A Snapshots, quarterly reviews and thematic landscape reports. Notable disclosed transactions include advising Medicare Insourcing Services on its Bay Tree Private Equity investment (2026), Sano Physiotherapy on its secondary MBO with Bestport Private Equity (2025), Audiological Science Limited on a YFM-backed £12.35m MBO (2025), Bridge Medical Consulting on its sale to THL-backed Red Nucleus, and historic deals across HealthHarmonie, Fox Covert, Lucis Pharma, Enable Therapy Services and Peak Education.

Name

Eclipse Corporate Finance

Legal name

Eclipse Corporate Finance Limited

Website

https://eclipsecf.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

Eclipse Corporate Finance is a boutique M&A advisory firm exclusively focused on the UK healthcare sector. It advises founders of healthcare businesses generating £1m–£5m EBITDA on company sales, private equity investments, and management buy-outs.

Ownership category

akta.pro rank

Product category

Mergers & Acquisitions Advisory

NAICS

Management Consulting Services (54161)

SIC

Services-Engineering, Accounting, Research, Management (8700)

akta.pro industry

PRIMARYBPAHAOAA

M&A Advisory (Buy-Side & Sell-Side)

Business & Public Services/Professional Services (Legal, Accounting, Consulting)/M&A, Transaction & Restructuring Advisory

SECONDARYBPAHADAB

Corporate Finance & Capital Advisory

Business & Public Services/Professional Services (Legal, Accounting, Consulting)/Strategy & Corporate Finance Advisory

Keywords

• Healthcare M&A advisory
• Mergers and acquisitions
• Company sale advisory
• Private equity transactions
• Management buy-outs

Headquarters

HQ city

Chipping Norton

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Marketing or Sales, Operations

Revenue model

1. M&A Advisory Fees: Eclipse generates revenue through advising healthcare business owners on company sales, private equity investments, and management buy-outs. The firm's fees are transparent and directly linked to the valuation achieved. As a boutique advisory firm with a selective deal focus (businesses generating £1m–£5m of annual profit), revenue is event-driven, tied to transaction completion.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Eclipse Corporate Finance is a boutique M&A advisory firm exclusively focused on the UK healthcare sector. It advises healthcare business owners (typically generating £1m–£5m EBITDA) on company sales, private equity investments, and management buy-outs, with fees linked to the transaction valuation achieved.

Product overview

Eclipse Corporate Finance is a boutique M&A advisory firm with an exclusive focus on the UK healthcare sector. The company offers a unified advisory service centered on healthcare M&A transactions, specifically company sales, private equity transactions (including management buy-outs and capital raises), and strategic advice. The firm specializes in advising businesses generating between £1m and £5m of profit. Eclipse covers the full spectrum of healthcare sectors, with core focus areas including Clinical Services, Digital Health & Software, Dental Practices & Labs, Specialist Residential Care, Children's Services & SEN Schools, Care Homes, Day Nurseries, Homecare/Domiciliary Care, Veterinary Services, and Pharma Services.

Differentiator

Problem solved

Functional benefit

Products and services

• Company Sales Advisory services for healthcare business owners looking to sell their companies, supporting them from preparation through to completion.
• Private Equity Transactions Advisory services for healthcare businesses taking on private equity investment, including management buy-outs and capital raises.
• Strategic Advice Advisory services providing market insights and strategic guidance for healthcare business owners considering transactions.

Named customers9 records

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators3 records

Recent moves6 records

Expansion highlights4 records

Direct peers

• Candesic: UK-based healthcare-focused strategy and M&A advisory firm advising on transactions across healthcare sub-sectors. Closest direct comparable in terms of exclusive healthcare focus and UK SME/mid-market client base, with overlap on clinical services, dental and care home mandates.
• Alantra: Independent European financial advisory with a dedicated UK Healthcare & Life Sciences practice advising on M&A, debt and equity transactions. Comparable for healthcare SME sell-side and PE-raise mandates, though with broader sector coverage and larger mid-market deal capability.
• Drake Star Partners: Global technology and healthcare-focused M&A advisory with a strong UK healthcare and digital health practice. Directly comparable for digital health, software and pharma services mandates, with overlapping buyer universe among PE-backed platforms and strategics.
• IMAP: Global mid-market M&A advisory network with UK healthcare dealmakers advising on sell-side and buy-side transactions. Comparable for healthcare SME/Mid-market M&A, though IMAP covers multiple sectors whereas Eclipse is exclusively healthcare.
• Clearwater International: Mid-market M&A advisory with a UK Healthcare team advising on company sales, MBOs and private equity transactions. Directly comparable for healthcare SME sell-side work, with overlapping target client profile (£1m–£10m+ EBITDA) and similar buyer universe of PE-backed platforms and strategics.

Broad incumbents

• Lincoln International: Global mid-market M&A advisory with a European Healthcare team advising on pharma services, medtech and care transactions. Comparable for healthcare SME and mid-market M&A mandates, particularly in pharma services, but covers multiple sectors.
• Grant Thornton UK Corporate Finance: UK advisory practice with a Healthcare M&A team advising PE-backed platforms, founder-led businesses and corporates on healthcare transactions. Comparable client overlap (NHS insourcing, clinical services, pharma services) but a significantly larger mid-market deal capability.
• BDO UK Corporate Finance: UK member firm of BDO with a dedicated Healthcare M&A team advising on mid-market company sales, private equity and MBOs. Overlaps with Eclipse on the £1m–£5m EBITDA target segment but offers broader sector coverage and a larger team.
• Houlihan Lokey: Global advisory firm with European healthcare M&A capability covering pharma services, healthcare IT and clinical services. Overlaps with Eclipse on pharma services and digital health sub-sectors but operates at larger deal sizes and with a broader geographic footprint.
• KPMG UK Corporate Finance (Healthcare): Big Four advisory practice with a dedicated UK Healthcare M&A team advising on NHS-facing transactions, clinical services and pharma services. Competes with Eclipse on UK healthcare sell-side mandates at the upper end of the SME/mid-market.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/eclipse-corporate-finance

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Eclipse Corporate Finance